Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland 21287
3 studies enrolling now · 31 studies all time
What they study most
Acute Leukemias of Ambiguous Lineage, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Megakaryoblastic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia, Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia, Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
Studies at this site
- Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer — Recruiting now
- Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer — Recruiting now
- Renal Retention in High Grade Upper Tract Urothelial Cancer — Recruiting now
- A Study of NPX887 for Participants With Solid Tumors Known to Express B7-H7/HHLA2 — Recruiting now
- Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the Bladder — Running, not enrolling
- Intravesical Gemcitabine and Docetaxel for BCG naïve Non-muscle Invasive Bladder Cancer — Running, not enrolling
- NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy — Running, not enrolling
- A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7 — Paused
- Carboplatin With or Without Atezolizumab in Treating Patients With Stage IV Triple Negative Breast Cancer — Completed
- An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma — Completed
- Phase 2 Study of Docetaxel +/- OGX-427 in Patients With Relapsed or Refractory Metastatic Bladder Cancer — Completed
- Dovitinib in BCG Refractory Urothelial Carcinoma With FGFR3 Mutations or Over-expression — Stopped early
- Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma — Completed
- Phase II PAP Plus GM-CSF Versus GM-CSF Alone for Non-metastatic Prostate Cancer — Completed
- Azacitidine and Entinostat in Treating Patients With Recurrent Advanced Non-Small Cell Lung Cancer — Completed
- Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy — Completed
- Alvocidib, Cytarabine, and Mitoxantrone Hydrochloride or Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia — Completed
- Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors — Completed
- A Comparison of FLT to FDG PET/CT in the Early Assessment of Chemotherapy Response in Stage IB-IIIA Resectable NSCLC — Completed
- Cediranib Maleate in Treating Patients With Relapsed, Refractory, or Untreated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome — Completed
- Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma — Completed
- Cytarabine With or Without SCH 900776 in Treating Adult Patients With Relapsed Acute Myeloid Leukemia — Completed
- Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia — Completed
- RO4929097 and Vismodegib in Treating Patients With Breast Cancer That is Metastatic or Cannot Be Removed By Surgery — Stopped early
- Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent Glioblastoma — Completed
- Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia — Completed
- Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer — Completed
- Comparison of Two Different Doses of STI571 in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor — Stopped early
- Azacitidine and Entinostat in Treating Patients With Metastatic Colorectal Cancer — Completed
- Entinostat and Clofarabine in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Poor-Risk Acute Lymphoblastic Leukemia or Bilineage/Biphenotypic Leukemia — Completed
- Melanoma Biomarker Study — Completed